Special Issue

Topic: What More We can do on Hepatitis C?

A Special Issue of Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

Submission deadline: 30 Apr 2018

Guest Editor(s)

Necati Örmeci, MD
Department of Gastroenterology, Ankara University Medical School, Ankara, Turkey.

Special Issue Introduction

Hepatitis C virus (HCV) is an enveloped virus with a 9.6 kb single stranded RNA genome. Six HCV genotypes and a large number of subtypes have been identified. HCV is an important world-wide health and economic problem through direct and indirect medical cost associated with managing liver disease, and decreased work productivity. A hundred and eighty million people are infected with HCV in the world. It is the cause of acute hepatitis, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Besides that, it may result in extra-hepatic manifestations such as mixed cryoglobulinemia, chronic kidney disease, porphyria cutaneatarda, and type 2 diabetes mellitus, rheumatoid-like nondestructive inflammatory arthritis and depression. HCV is associated with the increasing liver-related mortality.
HCV is one of the important factors (20 % of all causes) for developing HCC. Almost 700,000 persons died from HCC in a year. HCC is the 6th most common cancer but the third most common cause of death from the cancer.
Those are the reasons why we made a plan to establish a Special Issue about "What More Can We Do on Hepatitis C?". It is hoped that this Special Issue will bring novel insights and new solutions to the liver cancer research field.

Submission Deadline

30 Apr 2018

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/hr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=hr
Submission Deadline: 30 Apr 2018
Contacts: Siqi Li, Assistant Editor, editor001@hrjournal.net

Published Articles

HCC incidence and recurrence after DAAs: new insights

Open Access Editorial DOI: 10.20517/2394-5079.2019.14 17 Apr 2019
Views: Downloads:
Download PDF

Direct-acting antivirals and chronic hepatitis C: towards elimination

Open Access Review DOI: 10.20517/2394-5079.2018.94 13 Dec 2018
Views: Downloads:
Download PDF

Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan

Open Access Original Article DOI: 10.20517/2394-5079.2018.31 29 Nov 2018
Views: Downloads:
Download PDF

HCV elimination: breaking down the barriers to prison based care

Open Access Review DOI: 10.20517/2394-5079.2018.53 16 Oct 2018
Views: Downloads:
Download PDF

HCV-discovery to elimination, “myth or reality”

Open Access Review DOI: 10.20517/2394-5079.2018.36 19 Sep 2018
Views: Downloads:
Download PDF

Screening for hepatocellular carcinoma: summary of current guidelines up to 2018

Open Access Review DOI: 10.20517/2394-5079.2018.49 15 Aug 2018
Views: Downloads:
Download PDF

Elimination of hepatitis from Pakistan by 2030: is it possible?

Open Access Opinion DOI: 10.20517/2394-5079.2018.58 13 Aug 2018
Views: Downloads:
Download PDF

Factors predicting hepatocellular carcinoma in hepatitis C infection

Open Access Review DOI: 10.20517/2394-5079.2018.26 7 Aug 2018
Views: Downloads:
Download PDF

Heat shock reduces HCV replication via regulation of ribosomal L22 in Alu-RNA molecule dependent manner

Open Access Original Article DOI: 10.20517/2394-5079.2018.30 6 Aug 2018
Views: Downloads:
Download PDF

Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals

Open Access Review DOI: 10.20517/2394-5079.2018.54 17 Jul 2018
Views: Downloads:
Download PDF

Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Open Access Review DOI: 10.20517/2394-5079.2018.57 26 Jun 2018
Views: Downloads:
Download PDF

Molecular targeting of antiviral drugs used against hepatitis C virus infection

Open Access Review DOI: 10.20517/2394-5079.2018.25 25 Jun 2018
Views: Downloads:
Download PDF

Ablative techniques in hepatocellular carcinoma treatment

Open Access Review DOI: 10.20517/2394-5079.2018.22 12 Jun 2018
Views: Downloads:
Download PDF
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/